Showing results (701-710 of 1,271) with videos related to
Sort By:
Pageof 128
Psychopharmacology Bulletin|January 1, 1991
The use of antidepressants for negative symptoms in a subset of schizophrenic patientsS G Siris, P C Bermanzohn, A Gonzalez, et al.Psychopharmacology Bulletin|January 1, 1991
Effects of unilateral-nondominant vs. bilateral ECT on memory and depression: a preliminary reportP G Janicak, R P Sharma, T H Israni, et al.Psychopharmacology Bulletin|January 1, 1991
Long-term alprazolam use: abuse, dependence or treatment?M K Romach, U E Busto, L C Sobell, et al.Psychopharmacology Bulletin|April 18, 2012
Zonisamide for bipolar disorder, mania or mixed states: a randomized, double blind, placebo-controlled adjunctive trialDeborah Dauphinais, Michael Knable, Joshua Rosenthal, et al.Psychopharmacology Bulletin|April 18, 2012
Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical reviewTakefumi SuzukiPsychopharmacology Bulletin|January 1, 1990
Current pharmacotherapies for opioid dependenceT R KostenPsychopharmacology Bulletin|January 1, 1990
The pharmacotherapy of depressive illness in adolescence: I. An open label trial of imipramineM Strober, R Freeman, J RigaliPsychopharmacology Bulletin|January 1, 1990
Double-blind placebo-controlled study of nortriptyline in depressed adolescents using a "fixed plasma level" designB Geller, T B Cooper, D L Graham, et al.Psychopharmacology Bulletin|January 1, 1990
Platelet prostaglandin E1 hyposensitivity in schizophrenia: decrease in cyclic AMP formation and in inhibitory effects on aggregationH Kaiya, M Ofuji, M Nozaki, et al.Psychopharmacology Bulletin|January 1, 1990
Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorderW T Smith, V Glaudin, J Panagides, et al.Pageof 128